FierceBiotech

Boston Scientific claims European approval for Farapoint focal pulsed field ablation catheter

Boston Scientific has obtained an approval in Europe for the latest addition to its pulsed field ablation portfolio, with the Farapoint focal catheter. The CE mark brings a new indication to the ...
Nasdaq

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use (IFU) ...
FierceBiotech

Boston Scientific expands Farapulse’s reach in afib with new FDA approval

Boston Scientific has claimed a new approval from the FDA for its Farapulse pulsed field ablation system, expanding its use into patients with persistent atrial fibrillation lasting at least seven ...
Healio

FDA approves expanded indication of pulsed field ablation systems for persistent AF

Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication for Boston Scientific’s pulsed field ablation catheter for refractory, ...
MD&M East

Zapping Afib: How Pulsed Field Ablation is Electrifying a $10B Market

Boston Scientific leads the pulsed field ablation (PFA) technology market to treat atrial fibrillation (Afib). But it is by no means alone in its commitment to this relatively new way to treat some ...
MD&M East

Boston Scientific Secures Watchman Label Expansion

Boston Scientific has secured label expansion from FDA for its Watchman FLX and Watchman FLX Pro. The Marlborough, MA-based company had already expected the label expansion, which now includes ...